157915-07-6 Usage
General Description
8-Nitroquinoline-6-carboxylic acid is a chemical compound with the molecular formula C10H6N2O4. It is a nitro-substituted quinoline derivative, which is commonly used as an intermediate for the synthesis of various pharmaceuticals and organic compounds. It is an important building block in the production of antibacterial and antitumor drugs. The compound is also used as a fluorescent probe for detecting metal ions and as a precursor for the synthesis of fluorescent dyes and chelating agents. Additionally, 8-Nitroquinoline-6-carboxylic acid has potential applications in the field of material science for the fabrication of luminescent materials and chemical sensors.
Check Digit Verification of cas no
The CAS Registry Mumber 157915-07-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,7,9,1 and 5 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 157915-07:
(8*1)+(7*5)+(6*7)+(5*9)+(4*1)+(3*5)+(2*0)+(1*7)=156
156 % 10 = 6
So 157915-07-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H6N2O4/c13-10(14)7-4-6-2-1-3-11-9(6)8(5-7)12(15)16/h1-5H,(H,13,14)
157915-07-6Relevant articles and documents
Carbapenem antibiotic compounds
-
, (2008/06/13)
The present invention relates to carbapenems and provides a compound of the formula (I) STR1 wherein: R1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R2 is hydrogen or C1-4 alkyl; R3 is hydrogen or C1-4 alkyl; P1 is of the formula: STR2 and one or two of A,B,C,D,E,F,G and H, are nitrogen and the remainder are CH; and P is bonded to the nitrogen of the linking carbamoyl group by a carbon atom, in either ring, is substituted by the carboxy group on a carbon atom, in either ring, and is optionally further substituted, by up to three substitutents, on a carbon atom, in either ring; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. Processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them are also described.
